08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
New York State lawmakers have approved broad legislation that will lower the burden on plaintiffs se...
Read More >
One Equity Partners has announced it acquired American Medical Technologies. American Medical Techn...
Read More >
In 2018, New York State and New York City lawmakers toughened their sexual harassment laws. But New ...
Read More >
In recent decisions, the Delaware Court of Chancery continued to follow the Delaware Supreme Court’...
Read More >
DRONES - Balancing New Technology and Privacy When Using Drones in Land Use and Construction - The...
Read More >
World Law Group member firms recently collaborated on a Global Venture Capital Guide that covers mor...
Read More >